Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,300,229
  • Shares Outstanding, K 381,299
  • Annual Sales, $ 87,241 K
  • Annual Income, $ -73,963 K
  • 60-Month Beta 1.22
  • Price/Sales 10.87
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade CRON.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.11 on N/A
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Options Overview Details

View History
  • Implied Volatility 0.00% ( -68.13%)
  • Historical Volatility 56.28%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 103.63% on 07/06/23
  • IV Low 0.00% on 04/25/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 48
  • Put/Call OI Ratio 0.98
  • Today's Open Interest 2,410
  • Open Int (30-Day) 2,902

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.00
  • Low Estimate -0.01
  • Prior Year -0.04
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.98 +14.43%
on 04/22/24
4.01 -14.96%
on 04/04/24
-0.14 (-3.94%)
since 03/22/24
3-Month
2.56 +33.20%
on 03/05/24
4.01 -14.96%
on 04/04/24
+0.70 (+25.83%)
since 01/24/24
52-Week
2.15 +58.60%
on 06/19/23
4.01 -14.96%
on 04/04/24
+0.94 (+38.06%)
since 04/24/23

Most Recent Stories

More News
Stocks in play: Cronos Group Inc.

Announced today the launch of Lord Jones® Chocolate Fusions, its exciting first entry into the chocolate ...

CRON.TO : 3.41 (+0.29%)
Cronos: Q4 Earnings Snapshot

Cronos: Q4 Earnings Snapshot

CRON.TO : 3.41 (+0.29%)
Cronos: Q3 Earnings Snapshot

Cronos: Q3 Earnings Snapshot

CRON.TO : 3.41 (+0.29%)
Stocks in play: Cronos Group Inc.

Announced the launch of two new THCV-infused products; Spinach FEELZâ„¢ Full Tilt THCV vape and gummy. ...

CRON.TO : 3.41 (+0.29%)
Global Cannabis Market Projected To Reach $444 Billion By 2030 As Consumption and Demand Skyrockets

EQNX::TICKER_START (OTCQB:LBUY),(NASDAQ:SNDL),(NASDAQ:TLRY),(NASDAQ:CGC),(NASDAQ:CRON) EQNX::TICKER_END

LBUY : 0.0250 (-14.38%)
CRON : 2.50 (+0.81%)
CRON.TO : 3.41 (+0.29%)
CGC : 8.74 (-2.56%)
WEED.TO : 12.27 (-0.49%)
TLRY : 1.8000 (-2.17%)
TLRY.TO : 2.52 (unch)
SNDL : 1.96 (-2.00%)
Stocks in play: Cronos Group Inc.

Today announces its 2023 second quarter business results. Net revenue of $19.0 million in Q2 2023 decreased ...

CRON.TO : 3.41 (+0.29%)
Cronos: Q2 Earnings Snapshot

Cronos: Q2 Earnings Snapshot

CRON.TO : 3.41 (+0.29%)
Cronos: Q1 Earnings Snapshot

Cronos: Q1 Earnings Snapshot

CRON.TO : 3.41 (+0.29%)
Stocks in play: Cronos Group Inc.

In honour of Earth Day, released a Sustainability Study, which outlines the benefits of using fermentation ...

CRON.TO : 3.41 (+0.29%)
Cronos: Q4 Earnings Snapshot

Cronos: Q4 Earnings Snapshot

CRON.TO : 3.41 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the...

See More

Key Turning Points

3rd Resistance Point 3.64
2nd Resistance Point 3.56
1st Resistance Point 3.49
Last Price 3.41
1st Support Level 3.34
2nd Support Level 3.26
3rd Support Level 3.19

See More

52-Week High 4.01
Last Price 3.41
Fibonacci 61.8% 3.30
Fibonacci 50% 3.08
Fibonacci 38.2% 2.86
52-Week Low 2.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar